Target intelligence / Profile preview

RNA, variant U1 small nuclear 24 (RNVU1-24)

Target
RNVU1-24
Molecular classification
Non-coding RNA, Small nuclear RNA (snRNA) pseudogene, Other
01

Overview

RNVU1-24 (RNA, variant U1 small nuclear 24) is a pseudogene for U1 small nuclear RNA, designated HGNC:48401 and NCBI Gene:106480167[5][7]. It is also known as RNU1-59P, RNA U1 small nuclear 59, pseudogene. The U1 snRNA gene family encodes small nuclear RNAs essential for pre-mRNA splicing, but pseudogenes like RNVU1-24 contain sequence variations that disrupt the canonical functions and generally cannot encode functional proteins or snRNAs[4][5]. Although once considered nonfunctional, some snRNA pseudogenes are transcribed and may have regulatory RNA-based roles, such as acting as decoys for microRNAs or influencing mRNA stability[4][6]. However, for RNVU1-24 specifically, there is no evidence of a major biological function, disease association, or therapeutic relevance[5][7]. It is not recognized as a drug target or biomarker in current molecular medicine. The gene is catalogued as a pseudogene in major databases with no confirmed functional annotations.

Other names
RNU1-59PRNA, U1 small nuclear 59, pseudogeneRNVU1-24
02

Mechanism of action

No known mechanisms for drugs targeting RNVU1-24. By analogy, pseudogene RNAs can influence gene expression by miRNA sponge/decoy activity, antisense interactions, or competing for regulatory factors.

03

Biological functions

No direct functional data for RNVU1-24.By analogy to other U1 snRNA variants and pseudogenes: possible involvement in regulation of gene expression via RNA-based mechanisms, such as acting as a microRNA decoy, contributing to antisense or competing transcripts, or rarely generating functional snRNAsCanonical U1 snRNAs regulate pre-mRNA splicing, mRNA processing, and transcriptome integrityPseudogene variants may have more subtle or context-dependent effects.
04

Disease associations

None documented for RNVU1-24.Some pseudogenes broadly implicated in the regulation of tumor suppressors/onco-genes and may be deregulated in cancerNo evidence for direct involvement of this specific pseudogene in disease.

Beyond the preview

Go deeper on RNA, variant U1 small nuclear 24 (RNVU1-24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, variant U1 small nuclear 24 (RNVU1-24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call